Question 1

Who are the key players in North America Next-Generation Sequencing Market industry?

Accepted Answer

The top 5 players are Illumina, Thermo Fisher Scientific, Pacific Biosciences, Agilent Technologies, and Qiagen. These companies dominate the market with advanced platforms, comprehensive genomic solutions, and strong R&D investments, enabling adoption across clinical research, diagnostics, and pharmaceutical sectors in North America.

Question 2

What is the North America Next-Generation Sequencing Market growth?

Accepted Answer

The North America Next-Generation Sequencing Market has seen significant growth, with a CAGR exceeding 15% in recent years, driven by increasing adoption in clinical diagnostics and personalized medicine. In 2023, Illumina reported notable revenue increase owing to expanding applications in oncology and rare diseases.

Question 3

Which segment accounted for the largest North America Next-Generation Sequencing Market share?

Accepted Answer

The oncology application segment accounted for the largest market share, driven by rising cancer prevalence and the demand for precision medicine. NGS enables comprehensive genomic profiling in cancer research, aiding in targeted therapies and clinical decision-making, as widely adopted by hospitals and research institutes.

Question 4

What are the factors driving the North America Next-Generation Sequencing Market?

Accepted Answer

Key drivers include advancements in sequencing technologies, decreasing costs, and expanding applications in clinical diagnostics. For example, Thermo Fisher Scientific's launch of cost-effective high-throughput sequencers has enabled broader access for genomic analysis in healthcare, accelerating the market’s adoption and growth.

Question 5

Which type accounted for the largest North America Next-Generation Sequencing Market share?

Accepted Answer

The sequencing by synthesis (SBS) technology, mainly popularized by Illumina, holds the largest market share due to its high accuracy, throughput, and scalability. Its robust performance and wide compatibility with various genomic applications make SBS the preferred choice among research institutions and clinical laboratories.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5450
Regions	United States, Canada, Mexico
Segments	Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, RNA Sequencing, Methylation Sequencing, Other Types; Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agricultural & Animal Research, Others; Distribution Channels; Technology; Organization Size
Players	Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, BGI Genomics, Agilent Technologies, QIAGEN, F. Hoffmann-La Roche, PerkinElmer, Eurofins Scientific, Macrogen, Genomatix, Genapsys, GENEWIZ, Bio-Rad Laboratories

North America Next-Generation Sequencing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Market Segmentation

Frequently asked questions